Epigenetic Modifiers in Acute Myeloid Leukemia: Prognostic and Therapeutic Implications

Learning Objectives:

• Translate the importance of epigenetic regulators in the classification and prognosis of patients with AML.
• Awareness of AML subsets can be used to inform rational treatment strategies.

Cecilia Y. Arana Yi, M.D.
Senior Associate Consultant - Arizona Hematology/Oncology

Mayo Clinic - Phoenix, Arizona

LOCATION  Virtually, via Zoom

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

ABOUT Cancer Center Grand Rounds are held weekly on Thursdays for faculty and junior faculty, investigators and junior investigators, scholars, graduate students, medical students, research fellows, administration and allied health staff.

ARCHIVED PRESENTATIONS Located in Arizona Cancer Center Grand Rounds Video Library

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.